Bridgette Jeanne Billioux1. 1. National Institutes of Neurological Diseases and Stroke National Institutes of Health, 10 Center Drive, Room 5C-103, Bethesda, MD, 20892, USA. Bridgette.billioux@nih.gov.
Abstract
PURPOSE OF REVIEW: The recent 2014-2016 outbreak of Ebola virus disease (EVD) has led to many discoveries regarding Ebola. Although neurological symptoms during EVD had been previously described, many reports since this outbreak have made clear that EVD can lead to neurological issues. This article will review the various neurological manifestations of EVD. RECENT FINDINGS: Recently, many neurological symptoms have been described during acute EVD, including altered mental status, seizures, and meningoencephalitis, among others; survivors of EVD also may develop neurological sequelae, such as persistent headache and memory loss and can exhibit abnormalities on neurological exam. Additionally, it is now evident that in rare cases, survivors may experience relapses of EVD months after recovery, including the central nervous system (CNS). EVD can result in many clinical neurological manifestations, both acutely and after recovery. Research is ongoing to further clarify the nature of Ebola in the CNS.
PURPOSE OF REVIEW: The recent 2014-2016 outbreak of Ebola virus disease (EVD) has led to many discoveries regarding Ebola. Although neurological symptoms during EVD had been previously described, many reports since this outbreak have made clear that EVD can lead to neurological issues. This article will review the various neurological manifestations of EVD. RECENT FINDINGS: Recently, many neurological symptoms have been described during acute EVD, including altered mental status, seizures, and meningoencephalitis, among others; survivors of EVD also may develop neurological sequelae, such as persistent headache and memory loss and can exhibit abnormalities on neurological exam. Additionally, it is now evident that in rare cases, survivors may experience relapses of EVD months after recovery, including the central nervous system (CNS). EVD can result in many clinical neurological manifestations, both acutely and after recovery. Research is ongoing to further clarify the nature of Ebola in the CNS.
Authors: G Marshall Lyon; Aneesh K Mehta; Jay B Varkey; Kent Brantly; Lance Plyler; Anita K McElroy; Colleen S Kraft; Jonathan S Towner; Christina Spiropoulou; Ute Ströher; Timothy M Uyeki; Bruce S Ribner Journal: N Engl J Med Date: 2014-11-12 Impact factor: 91.245
Authors: Suzanne E Mate; Jeffrey R Kugelman; Tolbert G Nyenswah; Jason T Ladner; Michael R Wiley; Thierry Cordier-Lassalle; Athalia Christie; Gary P Schroth; Stephen M Gross; Gloria J Davies-Wayne; Shivam A Shinde; Ratnesh Murugan; Sonpon B Sieh; Moses Badio; Lawrence Fakoli; Fahn Taweh; Emmie de Wit; Neeltje van Doremalen; Vincent J Munster; James Pettitt; Karla Prieto; Ben W Humrighouse; Ute Ströher; Joseph W DiClaro; Lisa E Hensley; Randal J Schoepp; David Safronetz; Joseph Fair; Jens H Kuhn; David J Blackley; A Scott Laney; Desmond E Williams; Terrence Lo; Alex Gasasira; Stuart T Nichol; Pierre Formenty; Francis N Kateh; Kevin M De Cock; Fatorma Bolay; Mariano Sanchez-Lockhart; Gustavo Palacios Journal: N Engl J Med Date: 2015-10-14 Impact factor: 91.245
Authors: F M Baggi; A Taybi; A Kurth; M Van Herp; A Di Caro; R Wölfel; S Günther; T Decroo; H Declerck; S Jonckheere Journal: Euro Surveill Date: 2014-12-11
Authors: K Kibadi; K Mupapa; K Kuvula; M Massamba; D Ndaberey; J J Muyembe-Tamfum; M A Bwaka; A De Roo; R Colebunders Journal: J Infect Dis Date: 1999-02 Impact factor: 5.226
Authors: Daniel S Chertow; Avindra Nath; Anthony F Suffredini; Robert L Danner; Daniel S Reich; Rachel J Bishop; Richard W Childs; Andrew E Arai; Tara N Palmore; H Clifford Lane; Anthony S Fauci; Richard T Davey Journal: Ann Intern Med Date: 2016-04-05 Impact factor: 25.391
Authors: Timothy K Cooper; Louis Huzella; Joshua C Johnson; Oscar Rojas; Sri Yellayi; Mei G Sun; Sina Bavari; Amanda Bonilla; Randy Hart; Peter B Jahrling; Jens H Kuhn; Xiankun Zeng Journal: Sci Rep Date: 2018-01-19 Impact factor: 4.379